Cell-penetrating peptide TAT-mediated delivery of acidic FGF to retina and protection against ischemia-reperfusion injury in rats

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 7, 2010, Pages 1998-2005

  Wang, Yi ^a,c   Lin, Haihuan ^a   Lin, Shaoqiang ^a   Qu, Jia ^b   Xiao, Jian ^a   Huang, Yadong ^d   Xiao, Yechen ^e   Fu, Xiaobing ^f   Yang, Yongguang ^c   Li, Xiaokun ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b EYE HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d JINAN UNIVERSITY   (China)

^e JILIN AGRICULTURAL UNIVERSITY   (China)

^f CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Cell penetrating peptide; Fibroblast growth factor; Ischemia and reperfusion injury; Retina; Transactivator of transcription peptide

Indexed keywords

FIBROBLAST GROWTH FACTOR; TRANSACTIVATOR PROTEIN;

ANIMAL; ARTICLE; METABOLISM; RAT; REPERFUSION INJURY; RETINA;

ANIMALS; FIBROBLAST GROWTH FACTORS; GENE PRODUCTS, TAT; RATS; REPERFUSION INJURY; RETINA;

RATTUS;

EID: 77955778869     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00786.x     Document Type: Article

References (37)

1. Abes R, Arzumanov A, Moulton H. Arginine-rich cell penetrating peptides: design, structure-activity, and applications to alter pre-mRNA splicing by steric-block oligonucleotides. J Pept Sci. 2008, 14:455-60.
2. Johnson LN, Cashman SM, Kumar-Singh R. Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea. Mol Ther. 2008, 16:107-14.
3. Ryves WJ, Harwood AJ. Use of a penetratin-linked Peptide in dictyostelium. Mol Biotechnol. 2006, 33:123-32.
4. Berry CC, de la Fuente JM, Mullin M. Nuclear localization of HIV-1 tat functionalized gold nanoparticles. IEEE Trans Nanobioscience. 2007, 6:262-9.
5. Yang Z, Wang L, Wang H. A novel mimovirus vaccine containing survivin epitope with adjuvant IL-15 induces long-lasting cellular immunity and high antitumor efficiency. Mol Immunol. 2008, 45:1674-81.
6. Torchilin VP. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. Biopolymers. 2008, 90:604-10.
7. Liu L, Venkatraman SS, Yang YY. Polymeric micelles anchored with TAT for delivery of antibiotics across the blood-brain barrier. Biopolymers. 2008, 90:617-23.
8. Dietz GP, Valbuena PC, Dietz B. Application of a blood-brain-barrier-penetrating form of GDNF in a mouse model for Parkinson's disease. Brain Res. 2006, 1082:61-6.
9. Cronauer MV, Schulz WA, Seifert HH. Fibroblast growth factors and their receptors in urological cancers: basic research and clinical implications. Eur Urol. 2003, 43:309-19.
10. Cuevas P, Carceller F, Reimers D. Fibroblast growth factor-1 inhibits medial smooth muscle cells apoptosis after balloon injury. Neurol Res. 2000, 22:185-8.
11. Chen W, Fu XB, Ge SL. Intravenous acid fibroblast growth factor protects intestinal mucosal cells against ischemia-reperfusion injury via regulating Bcl-2/Bax expression. World J Gastroenterol. 2005, 11:3419-25.
12. Iwakura A, Fujita M, Ikemoto M. Myocardial ischemia enhances the expression of acidic fibroblast growth factor in human pericardial fluid. Heart Vessels. 2000, 15:112-6.
13. Nara N, Kurokawa H, Tohda S. The effect of basic and acidic fibroblast growth factors (bFGF and aFGF) on the growth of leukemic blast progenitors in acute myelogenous leukemia. Exp Hematol. 1995, 23:1030-4.
14. Lopez JJ, Edelman ER, Stamler A. Angiogenic potential of perivascularly delivered aFGF in a porcine model of chronic myocardial ischemia. Am J Physiol. 1998, 274:H930-6.
15. Thomas JW, Thieu TH, Byrd VM. Acidic fibroblast growth factor in synovial cells. Arthritis Rheum. 2000, 43:2152-9.
16. Jaye M, Lyall RM, Mudd R. Expression of acidic fibroblast growth factor cDNA confers growth advantage and tumorigenesis to Swiss 3T3 cells. EMBO J. 1988, 7:963-9.
17. Cuevas P, Carceller F, Reimers D. Acidic fibroblast growth factor rescues gerbil hippocampal neurons from ischemic apoptotic death. Neurol Res. 1998, 20:271-4.
18. Cuevas P, Carceller F, Cuevas B. A non-mitogenic form of acidic fibroblast growth factor reduces neutrophil infiltration in rat ischemic reperfused heart. Eur J Med Res. 1997, 2:139-43.
19. Cuevas P, Carceller F, Redondo-Horcajo M. Systemic administration of acidic fibroblast growth factor ameliorates the ischemic injury of the retina in rats. Neurosci Lett. 1998, 255:1-4.
20. Huang Y, Rao Y, Feng C. High-level expression and purification of Tat-haFGF19-154. Appl Microbiol Biotechnol. 2008, 77:1015-22.
21. Mukaida Y, Machida S, Masuda T. Correlation of retinal function with retinal histopathology following ischemia-reperfusion in rat eyes. Curr Eye Res. 2004, 28:381-9.
22. Coleman K, Fitzgerald D, Eustace P. Electroretinography, retinal ischaemia and carotid artery disease. Eur J Vasc Surg. 1990, 4:569-73.
23. Block F, Schwarz M, Sontag KH. Retinal ischemia induced by occlusion of both common carotid arteries in rats as demonstrated by electroretinography. Neurosci Lett. 1992, 144:124-6.
24. Richard JP, Melikov K, Vives E. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem. 2003, 278:585-90.
25. Ignatovich IA, Dizhe EB, Pavlotskaya AV. Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways. J Biol Chem. 2003, 278:42625-36.
26. Brooks H, Lebleu B, Vives E. Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev. 2005, 57:559-77.
27. Liu L, Guo K, Lu J. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. Biomaterials. 2008, 29:1509-17.
28. Cuevas P, Carceller F, Martinez-Coso V. Fibroblast growth factor cardioprotection against ischemia-reperfusion injury may involve K+ ATP channels. Eur J Med Res. 2000, 5:145-9.
29. Chen W, Fu XB, Ge SL. Exogenous acid fibroblast growth factor inhibits ischemia-reperfusion- induced damage in intestinal epithelium via regulating P53 and P21WAF-1 expression. World J Gastroenterol. 2005, 11:6981-7.
30. Lipton SA, Wagner JA, Madison RD. Acidic fibroblast growth factor enhances regeneration of processes by postnatal mammalian retinal ganglion cells in culture. Proc Natl Acad Sci USA. 1988, 85:2388-92.
31. Lee YS, Baratta J, Yu J. AFGF promotes axonal growth in rat spinal cord organotypic slice co-cultures. J Neurotrauma. 2002, 19:357-67.
32. Guo X, Hutcheon AE, Zieske JD. Transduction of functionally active TAT fusion proteins into cornea. Exp Eye Res. 2004, 78:997-1005.
33. Schwarze SR, Dowdy SF. In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol Sci. 2000, 21:45-8.
34. Schwarze SR, Ho A, Vocero-Akbani A. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science. 1999, 285:1569-72.
35. Violini S, Sharma V, Prior JL. Evidence for a plasma membrane-mediated permeability barrier to Tat basic domain in well-differentiated epithelial cells: lack of correlation with heparan sulfate. Biochemistry. 2002, 41:12652-61.
36. Barnett EM, Elangovan B, Bullok KE. Selective cell uptake of modified Tat peptide-fluorophore conjugates in rat retina in ex vivo and in vivo models. Invest Ophthalmol Vis Sci. 2006, 47:2589-95.
37. Dietz GP, Kilic E, Bahr M. Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction. Mol Cell Neurosci. 2002, 21:29-37.